Detection of metastatic neuroblastoma in bone marrow: When is routine marrow histology insensitive?

Journal of Clinical Oncology

Volumn 15, Issue 8, 1997, Pages 2807-2817

  Cheung, Nai Kong V ^a   Heller, Glenn ^a   Kushner, Brian H ^a   Liu, Chongyuan ^a   Cheung, Irene Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; GIEMSA STAIN; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; RELAPSE;

EID: 0030789888     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.8.2807     Document Type: Article

References (38)

1. Moss TJ, Reynolds P, Sather HN, et al: Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 324:219-226, 1991
2. Osborne MP, Rosen PP: Detection and management of bone marrow micrometastases in breast cancer. Oncology 8:25-42, 1994
3. Pantel K, Felber E, Schlimok G: Detection and characterization of residual disease in breast cancer. J Hematother 3:315-322, 1994
4. Pantel K, Izbicki J, Passlick B, et al: Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347:649-653, 1996
5. Woods DP, Banks ER, Humphreys S, et al: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74:2533-2540, 1994
6. Seeger R, Reynolds C: Treatment of high-risk solid tumors of childhood with intensive therapy and autologus bone marrow transplantation. Pediatr Clin North Am 38:393-424, 1991
7. Myers SE, Mick R, Williams SF: High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: A role for peripheral blood progenitor transplant. Bone Marrow Transpl 13:449-454, 1994
8. Brenner MK, Rill DR, Holladay MS, et al: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134-1137, 1993
9. Saarinen U, Wikstrom S, Makipernaa A, et al: In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation. J Clin Oncol 14:2791-2802, 1996
10. Stram DO, Matthay KK, O'Leary M, et al: Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma, in Evans AE, Biedler JL, Brodeur GM, et al (eds): Advances in Neuroblastoma Research 4, vol 385. New York, NY, Wiley-Liss, 1994, pp 287-292
11. Philip T, Ladenstein R, Lasset C, et al: Myeloablative megatherapy (MGT) procedures followed by stem cell rescue (SCR) for neuroblastoma (NBL): 17 years of European experience and conclusions. Eur J Cancer 1997 (in press)
12. Brugger W, Bross KJ, Glatt M, et al: Mobilization of tumor cells and hematopoietic progenitor cells into 'peripheral blood of patients with solid tumors. Blood 83:636-640, 1994
13. Sale GE: False positive diagnosis of pretransplant breast cancer in the bone marrow due to delayed fixation. Bone Marrow Transpl 10:98, 1992
14. Tsuchida Y, Yokoyama J, Kaneko, et al: Therapeutic significance of surgery in advanced neuroblastoma: A report from the Study Group of Japan. J Pediatr Surg 27:616-622, 1992
15. Kushner BH, O'Reilly RJ, LaQuaglia M, et al: Dose intensive use of cyclophosphamide in ablation of neuroblastoma. Cancer 66:1095-1100, 1990
16. Kushner BH, LaQuaglia MP, Bonilla MA, et al: Highly effective induction therapy for stage 4 neuroblastoma in children over one year of age. J Clin Oncol 12:2607-2613, 1994
17. Gaffney P, Hansman C, Fetterman G: Experience with smears of aspirates from bone marrow in the diagnosis of neuroblastoma. Am J Clin Pathol 31:213-221, 1959
18. D2 specific monoclonal antibodies. J Clin Oncol 4:363-369, 1986
19. Ye JN, Cheung NKV: A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies. Int J Cancer 50:197-201, 1992
20. Cheung IY, Cheung NKV: Molecular detection of GAGE expression in peripheral blood and bone marrow: Utility as a tumor marker for neuroblastoma. Clin Cancer Res 3:821-826, 1997
21. Naito H, Kuzumaki N, Uchino J, et al: Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 27:762-765, 1991
22. Cheung NK, Heller G: Chemotherapy dose intensity correlates strongly with response, median survival and median progression-free survival in metastatic neuroblastoma. J Clin Oncol 9:1050 -1058, 1991
23. Helson L, Denoix L: Four drug sequential chemotherapy for metastatic neuroblastoma. Eur J Cancer 9:883-885, 1973
24. Kushner BH, Helson L: Coordinated use of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: Experience with 100 patients. J Clin Oncol 5:1746-1751, 1987
25. Favrot MC, Frappaz D, Maritaz O, et al: Histological, cytological and immunological analyses are complementary for detection of neuroblastoma cells in bone marrow. Br J Cancer 54:637-641, 1986
26. Bostrom B: The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastoma. Am J Pediatr Hematol Oncol 7:303-305, 1985
27. Reid MM, Wallis JP, McGuckin AG, et al: Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma. J Clin Pathol 44:483-486, 1991
28. Reid MM: Detection of bone marrow infiltration by neuroblastoma in clinical practice: How far have we come? Eur J Cancer 30A: 134-135, 1994
29. Brodeur G, Seeger RC, Barrett A, et al: International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6:1874-1881, 1988
30. Evans AE, Kummeler K: The significance of primitive cells in marrow aspirates of children with neuroblastoma. Cancer 32:908-912, 1973
31. Harbeck N, Untch M, Pache L, Eiermann W: Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up. Br J Cancer 69:566-571, 1994
32. Sharp JG, Bishop M, Chan WC, et al: Detection of minimal residual disease in hematopoietic tissues. Ann NY Acad Sci 770:242-261, 1995
33. Trillet-Lenoir VN, Arpin D, Brune J: Bone marrow metastases detection in small cell lung cancer. A review. Anticancer Res 14:2795-2797, 1994
34. Allan PM, Garson JA, Harper EI, et al: Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer 31:591-598, 1983
35. Reynolds CP, Moss TJ, Seeger RC, et al: Sensitive detection of neuroblastoma cells in bone marrow for monitoring the efficacy of marrow purging procedures, in Evans AE (ed): Advances in Neuroblastoma Research, vol 175. New York, NY: 1985, pp 425-441
36. Yeh SD, Larson SM, Burch L, et al: Radioimmunodetection of neuroblastoma with iodine-131-3F8: Correlation with biopsy, iodine-131-Metaiodobenzylguanidine (MIBG) and standard diagnostic modalities. J Nucl Med 32:769-776, 1991
37. Pantel K, Schlimok G, Angstwurm M, et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3:165-173, 1994
38. Papac RJ: Bone marrow metastases. A review. Cancer 74:2403-2413, 1994